References
Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in “mild” hypertension. N Engl J Med. 1982;307:976–80.
Littenberg B, Garber A, Sox HC Jr. Screening for hypertension. Ann Intern Med. 1990;112:192–202.
Dahlof B, Lindholm L, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hyper-tension). Lancet. 1991;338:1281–5.
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90–114 mm Hg. JAMA. 1970;213:1143–52.
Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principle results. BMJ. 1985;291:97–104.
Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo Study. Am J Med. 1980;69:725–32.
SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255–64.
Furberg C, Psaty B, Meyer J. Nifedipine: dose-increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326–31.
Psaty B, Heckbert S, Koepsell T, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620–5.
Materson B, Reda D, Cushman W, et al. Single drug therapy for hypertension in men. N Engl J Med. 1993;328:914–21.
Neaton J, Grimm R, Prineas R, et al. Treatment of Mild Hypertension Study (TOMHS). JAMA. 1993;270:713–24.
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302.
Lewis E, Hunsicker L, Bain R, Rohds R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456–62.
Shub C. Stable angina pectoris: 3. Medical treatment. Mayo Clin Proc. 1990;65:256–73.
Pritchett ELC. Management of atrial fibrillation. N Engl J Med. 1992;326:1264–71.
Gaasch W. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA. 1994;271:1276–80.
Raskin N. Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale. Neurology. 1993;43(6 suppl 3):S39-S42.
Coe F, Parks J, Asplin J. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327:1141–52.
Odell TW, Gregory MC. Cost of hypertension treatment. J Gen Intern Med. 1995;10:686–8.
Stason W. Cost and quality tradeoffs in the treatment of hypertension. Hypertension. 1989;13(suppl 1):145I-148I.
Clark L. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991;121:664–9.
Sbarbaro J. The patient—physician relationship: compliance revisited. Ann Allergy. 1990;64:325–31.
Wright E. Noncompliance—or how many aunts has Matilda? Lancet. 1993;342:909–13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katzman, D.A., Littenberg, B. Choosing antihypertensive therapy. J Gen Intern Med 10, 700–702 (1995). https://doi.org/10.1007/BF02602771
Issue Date:
DOI: https://doi.org/10.1007/BF02602771